Despite the lack of change in CCL5 levels in ischemic stroke patients compared with healthy volunteers, we found a significant decrease, at admission, in patients whose stroke volume would grow, thus predicting a poorer outcome. This evidence concerns the gene CCL5 and ischemic stroke.